
### [NCIT:C7114](http://purl.obolibrary.org/obo/NCIT_C7114)
**Label:** Thymoma Type B

**Subclasses:** [NCIT:C6889](http://purl.obolibrary.org/obo/NCIT_C6889) (Malignant Type B2 Thymoma), [NCIT:C7997](http://purl.obolibrary.org/obo/NCIT_C7997) (Thymoma Type B3), [NCIT:C7996](http://purl.obolibrary.org/obo/NCIT_C7996) (Malignant Type B1 Thymoma), [NCIT:C6888](http://purl.obolibrary.org/obo/NCIT_C6888) (Thymoma Type B2), [NCIT:C6887](http://purl.obolibrary.org/obo/NCIT_C6887) (Thymoma Type B1), 

**Class expressions from DL-Learner:**

- [UBERON:0003846](http://purl.obolibrary.org/obo/UBERON_0003846) (thymus epithelium) 54.55%
- Thing 52.66%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C14089](http://purl.obolibrary.org/obo/NCIT_C14089) (Nuclear Localization Signal))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C14082](http://purl.obolibrary.org/obo/NCIT_C14082) (GTP Binding Domain))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C14080](http://purl.obolibrary.org/obo/NCIT_C14080) (DAG/PE-Binding Domain))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C14075](http://purl.obolibrary.org/obo/NCIT_C14075) (Tyrosine Kinase Domain))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C14042](http://purl.obolibrary.org/obo/NCIT_C14042) (BRCT Domain))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C14005](http://purl.obolibrary.org/obo/NCIT_C14005) (2p12))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C139627](http://purl.obolibrary.org/obo/NCIT_C139627) (Stage IV Vulvar Cancer AJCC v8))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C139623](http://purl.obolibrary.org/obo/NCIT_C139623) (Stage III Vulvar Cancer AJCC v8))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C139622](http://purl.obolibrary.org/obo/NCIT_C139622) (Stage II Vulvar Cancer AJCC v8))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C139619](http://purl.obolibrary.org/obo/NCIT_C139619) (Stage I Vulvar Cancer AJCC v8))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C139548](http://purl.obolibrary.org/obo/NCIT_C139548) (Vulvar Composite Papillary Hidradenoma and Fibroadenoma))) 39.90%
- [UBERON:0002370](http://purl.obolibrary.org/obo/UBERON_0002370) (thymus) and (not ([NCIT:C139546](http://purl.obolibrary.org/obo/NCIT_C139546) (Anal Ectopic Fibroadenoma))) 39.90%


